Medical Thawing System Market to Expand at 7.96% CAGR and Reach US$ 458.4 million by 2031

The Global Medical Thawing System Market was valued at $190.2 Million in 2020. Growing at a high CAGR of more than 7.96% between 2021 and 2031, it is estimated to reach $458.4 Million by 2031.
By: Sheer Analytics and Insights
MILWAUKEE - Nov. 8, 2021 - PRLog -- According to a global Medical Thawing System market report published by Sheer Analytics and Insights, the total market was valued at $190.2 million in 2020, growing at a commendable CAGR of 7.96% from 2021 to 2031. It is estimated to reach $458.4 million by 2031. North America dominated the global medical thawing system market in 2020 with a 39.2% market share in value terms. It is anticipated that Asia-Pacific will grow at the fastest growth rate of 8.1% through the forecast period. The increasing demand for medical thawing and growing investment in the healthcare industry restructuring are the factors in the development of the market.

Covid has impacted the market positively, as medical thawing systems had shown a good surge of 13.1% from 2019 end to 2020 end. The global medical thawing system market is mainly driven by increasing awareness and advantages of the system, increasing interest of people in donating blood, and rapid demand for advanced thawing solutions across developed and developing nations. The growth in demand for medical thawing systems due to post effects of Covid is anticipated to sustain throughout the forecast period; therefore, it is estimated to have a moderate positive impact on the global medical thawing system market in the short term.

Moreover, the rise in the incidence of transfusion-transmitted infections and healthcare-associated infections (HAI) have encouraged the need for next-gen thawing equipment. Advancements observed in cryopreservation techniques, especially for the embryo, blood, and red blood cells (RBC), and improvements in regenerative medicine have revealed new opportunities for players in the medical thawing system market.
  • In addition, frozen embryos for IVF procedures have shown significant growth in the past few years. It is expected to grow at CAGR of more than 20% through the forecast period too. Embryo freezing is the better option for specific groups, such as:
  • people with genetic disorders that affect reproduction
  • people who soon undergo chemotherapy
  • people who consume medications that affect fertility
  • LGBTQ+ and same-sex couples' people who wish to have children

Click full report at

According to the study, key players operating in this market are Helmer Scientific Inc., SARSTEDT AG & Co. KG, BioCision, LLC, GE Healthcare, Boekel Scientific, Barkey, Cardinal Health, GE Healthcare, Thermo Fisher Scientific, Cytotherm, Sartorius AG, Genesis PS, KW apparecchi scientifici, EMSA, and Meditech Technologies India Private Limited.

Media Contact
Abhigyan Sengupta
Sheer Analytics and Insights Pvt. Ltd. PRs
Trending News
Most Viewed
Top Daily News

Like PRLog?
Click to Share